JP2003502360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003502360A5 JP2003502360A5 JP2001504359A JP2001504359A JP2003502360A5 JP 2003502360 A5 JP2003502360 A5 JP 2003502360A5 JP 2001504359 A JP2001504359 A JP 2001504359A JP 2001504359 A JP2001504359 A JP 2001504359A JP 2003502360 A5 JP2003502360 A5 JP 2003502360A5
- Authority
- JP
- Japan
- Prior art keywords
- unit according
- oral administration
- administration unit
- present
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013543 active substance Substances 0.000 description 10
- 239000012730 sustained-release form Substances 0.000 description 9
- 238000013268 sustained release Methods 0.000 description 7
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 6
- 229960003107 tramadol hydrochloride Drugs 0.000 description 6
- 229960001193 diclofenac sodium Drugs 0.000 description 5
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 5
- 239000008188 pellet Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920003176 water-insoluble polymer Polymers 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical class C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000000014 opioid analgesic Substances 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005563 spheronization Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19927689A DE19927689A1 (de) | 1999-06-17 | 1999-06-17 | Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
| DE19927689.7 | 1999-06-17 | ||
| PCT/EP2000/005386 WO2000078294A2 (de) | 1999-06-17 | 2000-06-13 | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003502360A JP2003502360A (ja) | 2003-01-21 |
| JP2003502360A5 true JP2003502360A5 (https=) | 2011-08-25 |
| JP4889897B2 JP4889897B2 (ja) | 2012-03-07 |
Family
ID=7911586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001504359A Expired - Fee Related JP4889897B2 (ja) | 1999-06-17 | 2000-06-13 | トラマドールとジクロフェナクの固定組合せ物を投与するための経口投与形 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020156133A1 (https=) |
| EP (1) | EP1185253B1 (https=) |
| JP (1) | JP4889897B2 (https=) |
| AT (1) | ATE260650T1 (https=) |
| AU (1) | AU778151B2 (https=) |
| CA (1) | CA2377174C (https=) |
| DE (2) | DE19927689A1 (https=) |
| DK (1) | DK1185253T3 (https=) |
| ES (1) | ES2215680T3 (https=) |
| HK (1) | HK1045113A1 (https=) |
| HU (1) | HUP0201687A3 (https=) |
| MX (1) | MXPA01013046A (https=) |
| NZ (1) | NZ516593A (https=) |
| PT (1) | PT1185253E (https=) |
| WO (1) | WO2000078294A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10108122A1 (de) | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Arzneimittel auf Basis von Tramadol |
| US20030134810A1 (en) * | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
| EP1364649A1 (en) * | 2002-05-23 | 2003-11-26 | Cilag AG | Adduct of topiramate and tramadol hydrochioride and uses thereof |
| EA014685B1 (ru) | 2003-04-25 | 2010-12-30 | Джилид Сайэнс, Инк. | Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| AU2005330489B2 (en) | 2004-07-27 | 2011-08-25 | Gilead Sciences, Inc. | Nucleoside phosphonate conjugates as anti HIV agents |
| US20070009591A1 (en) * | 2005-07-07 | 2007-01-11 | Trivedi Jay S | ACE inhibitor formulation |
| NZ565108A (en) | 2005-07-07 | 2011-10-28 | Farnam Co Inc | Sustained release pharmaceutical compositions for highly water soluble drugs |
| EP1785412A1 (en) * | 2005-11-14 | 2007-05-16 | IPCA Laboratories Limited | Tramadol recovery process |
| DE102006006532B4 (de) * | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
| CA2645855C (en) | 2006-03-16 | 2015-02-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| JP2008208078A (ja) * | 2007-02-27 | 2008-09-11 | Takada Seiyaku Kk | 分割錠剤 |
| US8658617B2 (en) | 2008-07-08 | 2014-02-25 | Gilead Sciences, Inc. | Salts of HIV inhibitor compounds |
| DE102008056312A1 (de) | 2008-11-07 | 2010-05-12 | Biogenerics Pharma Gmbh | Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz |
| EP2593096A4 (en) * | 2010-07-12 | 2014-02-26 | Yung Shin Pharm Ind Co Ltd | DICLOFENAC SALT OF TRAMADOL |
| US8623409B1 (en) | 2010-10-20 | 2014-01-07 | Tris Pharma Inc. | Clonidine formulation |
| US8287903B2 (en) | 2011-02-15 | 2012-10-16 | Tris Pharma Inc | Orally effective methylphenidate extended release powder and aqueous suspension product |
| CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| SI3661937T1 (sl) | 2017-08-01 | 2021-11-30 | Gilead Sciences, Inc. | Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
| CN110755396B (zh) * | 2019-12-06 | 2022-04-08 | 北京悦康科创医药科技股份有限公司 | 一种布洛芬缓释小丸及其制备方法 |
| US11918689B1 (en) | 2020-07-28 | 2024-03-05 | Tris Pharma Inc | Liquid clonidine extended release composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
| DE3627423A1 (de) * | 1986-08-13 | 1988-02-18 | Thomae Gmbh Dr K | Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung |
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| US5919826A (en) * | 1996-10-24 | 1999-07-06 | Algos Pharmaceutical Corporation | Method of alleviating pain |
| DE19732928C2 (de) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
-
1999
- 1999-06-17 DE DE19927689A patent/DE19927689A1/de not_active Ceased
-
2000
- 2000-06-13 JP JP2001504359A patent/JP4889897B2/ja not_active Expired - Fee Related
- 2000-06-13 AU AU56805/00A patent/AU778151B2/en not_active Ceased
- 2000-06-13 NZ NZ516593A patent/NZ516593A/en not_active IP Right Cessation
- 2000-06-13 CA CA002377174A patent/CA2377174C/en not_active Expired - Fee Related
- 2000-06-13 HK HK02106641.8A patent/HK1045113A1/zh unknown
- 2000-06-13 PT PT00942052T patent/PT1185253E/pt unknown
- 2000-06-13 DE DE50005529T patent/DE50005529D1/de not_active Expired - Lifetime
- 2000-06-13 EP EP00942052A patent/EP1185253B1/de not_active Expired - Lifetime
- 2000-06-13 HU HU0201687A patent/HUP0201687A3/hu unknown
- 2000-06-13 WO PCT/EP2000/005386 patent/WO2000078294A2/de not_active Ceased
- 2000-06-13 MX MXPA01013046A patent/MXPA01013046A/es active IP Right Grant
- 2000-06-13 DK DK00942052T patent/DK1185253T3/da active
- 2000-06-13 AT AT00942052T patent/ATE260650T1/de active
- 2000-06-13 ES ES00942052T patent/ES2215680T3/es not_active Expired - Lifetime
-
2001
- 2001-12-17 US US10/016,130 patent/US20020156133A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003502360A5 (https=) | ||
| CA2377167C (en) | Multilayered tablet for administration of a fixed combination of tramadol and diclofenac | |
| US5859060A (en) | Timed release tablet comprising naproxen and pseudoepherine | |
| ES2208757T3 (es) | Composiciones de paroxetina con liberacion controlada. | |
| JP4889897B2 (ja) | トラマドールとジクロフェナクの固定組合せ物を投与するための経口投与形 | |
| CA2107332A1 (en) | Ibuprofen-antitussive combinations | |
| CA2601289A1 (en) | Once-a-day oxycodone formulations | |
| MXPA05008033A (es) | Composiciones de milnacipran en forma de multiparticulas para administracion oral. | |
| KR101464771B1 (ko) | 페닐에프린의 지속 방출용 약제학적 조성물 | |
| RU2322262C2 (ru) | Композиции нестероидных противовоспалительных лекарственных средств, противозастойных средств и антигистаминов | |
| EP1017388B1 (en) | Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine | |
| JP2011516544A5 (https=) | ||
| EP1604658A2 (en) | Pharmaceutical composition comprising ibuprofen and prochlorperazine | |
| CN101278933A (zh) | 一种含有二甲啡烷的药物组合物及其制备方法 | |
| CN101264080A (zh) | 一种含有右旋氯苯那敏的药用组合物及其制备方法 | |
| WO1992017171A1 (en) | Ibuprofen-decongestant combinations | |
| RU2166937C1 (ru) | Лекарственное средство на основе парацетамола | |
| WO2015157729A1 (en) | Pharmaceutical formulations an comprising analgesic agent, a nonsteroidal anti-inflammatory agent, a gastric acid production suppressant and an anti-nauseant | |
| JP2007536257A (ja) | 濃縮有効成分を含むソフトゲル封入医薬組成物 | |
| US5998478A (en) | Timed release tablet comprising naproxen and pseudoephedrine | |
| JP2006001920A (ja) | 医薬製剤 | |
| EP0555411A1 (en) | Dextromethorphan antitussive compositions | |
| US6663896B1 (en) | Delayed release aspirin for vascular obstruction prophylaxis | |
| US6099860A (en) | Controlled release oral preparation with naproxen sodium and pseudoephedrine | |
| Mahajan et al. | An overview on Superdisintegrants |